Treatments and predictors of mortality for carbapenem-resistant Gram-negative bacilli infections in Malaysia: a retrospective cohort study

U Abubakar, AI Zulkarnain, J Rodríguez-Baño… - Tropical Medicine and …, 2022 - mdpi.com
This study evaluated the treatments, mortality rate and patient-related factors associated with
mortality. This is a retrospective study involving hospitalised patients with infections caused …

[HTML][HTML] Prevalence of carbapenem non-susceptible gram-negative bacteria at tertiary care hospitals in Saudi Arabia

RI Aloraifi, AF Alharthi, AA Almefleh, AH Alamri… - Cureus, 2023 - ncbi.nlm.nih.gov
Background Antibiotics significantly increased life expectancy and decreased mortality rates
due to infections. However, this trend is starting to fade with the rise of multidrug-resistant …

[PDF][PDF] Risk factors for carbapenem resistant bacteraemia and mortality due to gram negative bacteraemia in a developing country

K Kalam, F Qamar, S Kumar, S Ali, S Baqi - J Pak Med Assoc, 2014 - academia.edu
Objective: To identify the risk factors for carbapenem resistant bacteraemia and mortality due
to gram negative bacteraemia in a developing country. Methods: A prospective cohort study …

Predictors of mortality in patients with infections due to carbapenem-resistant gram-negative bacteria

HO Rivera-Villegas, BA Martinez-Guerra… - Antibiotics, 2023 - mdpi.com
Introduction: Infections caused by carbapenem-resistant Gram-negative bacteria (CR-GNB)
are a significant cause of mortality and represent a serious challenge to health systems. The …

[HTML][HTML] Carbapenem-resistant Enterobacteriaceae (CRE) and gram-negative bacterial infections in south-west Nigeria: a retrospective epidemiological surveillance …

OA Adesanya, HA Igwe - AIMS Public Health, 2020 - ncbi.nlm.nih.gov
Background Carbapenem-resistant Enterobacteriaceae (CRE) are often responsible for
severe, life-threatening infections and they represent a critical threat to the available …

[HTML][HTML] Prevalence and 30-day all-cause mortality of carbapenem-and colistin-resistant bacteraemia caused by Acinetobacter baumannii, Pseudomonas aeruginosa …

A Balkhair, Z Al-Muharrmi, B Al'Adawi… - International Journal of …, 2019 - Elsevier
Background Bacteraemia due to carbapenem-resistant gram-negative bacteria is
challenging. This study examined the burden of carbapenem and colistin resistance in …

Changing epidemiology and decreased mortality associated with carbapenem-resistant gram-negative bacteria, 2000–2017

A Babiker, LG Clarke, M Saul, JA Gealey… - Clinical Infectious …, 2021 - academic.oup.com
Background Carbapenem-resistant gram-negative bacteria (CRGNB) continue to present a
global healthcare crisis. We aimed to identify emerging trends of CRGNB over nearly 2 …

[HTML][HTML] Clinical management of severe infections caused by carbapenem-resistant gram-negative bacteria: a worldwide cross-sectional survey addressing the use of …

E Carrara, A Savoldi, LJV Piddock, F Franceschi… - Clinical Microbiology …, 2022 - Elsevier
Objectives Optimal treatment of carbapenem-resistant Gram-negative bacteria (CR-GNB)
infections is uncertain because of the lack of good-quality evidence and the limited …

The prevalence of Carbapenem resistance gram negative pathogens in a tertiary teaching hospital in Jordan

KA Hammour, R Abu-Farha, R Itani, S Karout… - BMC Infectious …, 2023 - Springer
Background With the absence of new antimicrobial drugs being developed to replace those
facing resistance, bacterial resistance continues to grow. Despite previous studies …

[HTML][HTML] Epidemiology and mortality outcome of carbapenem-and colistin-resistant Klebsiella pneumoniae, Escherichia coli, Acinetobacter baumannii, and …

A Balkhair, K Al Saadi, B Al Adawi - IJID regions, 2023 - Elsevier
Background Bloodstream infections caused by carbapenem-resistant Gram-negative
bacteria represent a major therapeutic challenge to clinicians worldwide. This study …